Kane Biotech (TSE:KNE) has released an update.
Kane Biotech, a biotech company focused on biofilm prevention and removal technologies, has successfully raised $500,000 through the exercise of 5 million warrants. This influx of capital, supported by long-term investors, is set to bolster the company’s general working capital, reinforcing its operations and potential growth.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
